针对C-degron E3 KLHDC2参与的对应物特异性向蛋白质降解的原理2
Daniel C Scott1, Suresh Dharuman2, Elizabeth Griffith2
1Department of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Nature communications
|October 12, 2024
概括
这项研究介绍了KLHDC2作为一种新型E3结合酶,用于蛋白质溶解向合体 (PROTAC) 技术,可选择性降解BRD3.3等向蛋白质. 这扩大了针对蛋白质降解的PROTAC能力.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 向蛋白解酶的嵌合体 (PROTACs) 利用E3链酶来降解向蛋白质.
- 合作三元复合体的形成增强了PROTAC的选择性.
- 扩大E3链酶的谱系对于PROTAC的发展至关重要.
研究的目的:
- 为了研究C-degron E3结合酶KLHDC2对PROTAC介导的蛋白质降解.
- 使用KLHDC2.2开发针对BET家族蛋白质的新型PROTAC,特别是BRD3.
- 为了克服使用KLHDC2.2的PROTAC细胞透性的局限性.
主要方法:
- 针对KLHDC2的依据结构的设计和优化.
- 结合KLHDC2连接体与JQ1用于BET蛋白招募.
- 产生和选前药物变体以改善细胞透性.
- 在体外无处不在测定和细胞降解研究.
主要成果:
- 成功使用KLHDC2作为PROTAC诱导降解的E3酶.
- 开发了SJ46421,一个PROTAC,与BRD3.3形成了一个高度合作和选择性的三元复合体.
- 产品药物SJ46420在细胞中显示出有效的BRD3降解,克服了透性问题.
- 实现了KLHDC2对相关E3连接酶 (KLHDC1,KLHDC3,KLHDC10) 的选择性.
结论:
- 确定KLHDC2作为一种可行的E3结合酶,用于新基质特定的向蛋白质降解.
- 为设计使用C-degron E3结合酶的选择性PROTACs提供了一个框架.
- 证明了在BET家族内选择性降解BRD3的PROTACs的成功应用.
相关概念视频
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
The Proteasome
8.5K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.5K
Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
Protein Complexes with Interchangeable Parts
2.5K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.5K
The Proteasome Structure
712
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
712
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K


